1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Mental Health Analysis & Statistics, July 2019

Mental Health Analysis & Statistics, July 2019

Customer Support

Talk to Ahmad

+1 718 618 4302

1-30 of about 1900 reports

Pompe Disease - Market Insights, Epidemiology and Market Forecast-2028

Pompe Disease - Market Insights, Epidemiology and Market Forecast-2028

  • $ 9500
  • Industry report
  • July 2019

‘Pompe Disease - Market Insights, Epidemiology and Market Forecast-2028’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the emerging market ...

  • Industries : Mental Health, Therapy
Healthcare Services Global Market Opportunities And Strategies To 2022

Healthcare Services Global Market Opportunities And Strategies To 2022

  • $ 8000
  • Industry report
  • April 2019

Healthcare Services Global Market Opportunities And Strategies To 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global healthcare ...

  • Industries : Health Services, Healthcare
  • Countries : World
Parkinson’s Disease and Behavioral Complications: PD Therapies Dominate First-in-Class Pipeline, with Novel Target Classes Demonstrating Potential Disease-Modifying Effects

Parkinson’s Disease and Behavioral Complications: PD Therapies Dominate First-in-Class Pipeline, with Novel Target Classes Demonstrating Potential Disease-Modifying Effects

  • $ 6995
  • Industry report
  • May 2019

Parkinson’s Disease and Behavioral Complications: PD Therapies Dominate First-in-Class Pipeline, with Novel Target Classes Demonstrating Potential Disease-Modifying EffectsSummaryParkinson’s disease ...

  • Industries : Mental Health, Pathology
  • Countries : World
Epilepsy Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Epilepsy Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

  • $ 5795
  • Industry report
  • May 2019

Global Epilepsy Therapeutics Market: OverviewThis report analyzes the global epilepsy therapeutics market in terms of its current and future scenario.Epilepsy is a central nervous system disorder in which ...

  • Industries : Mental Health, Pharmaceutical, Therapy, Pathology
  • Countries : World, APAC
Childhood Absence Epilepsy Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

Childhood Absence Epilepsy Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • $ 4795
  • Industry report
  • June 2019

The report on the global childhood absence epilepsy treatment market provides qualitative and quantitative analysis for the period from 2017 to 2025.The report predicts the global childhood absence epilepsy ...

  • Industries : Mental Health, Pathology
  • Countries : World
Epilepsy Drug Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

Epilepsy Drug Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • $ 4795
  • Industry report
  • May 2019

The report on the global epilepsy drug market provides qualitative and quantitative analysis for the period from 2017 to 2025.The report predicts the global epilepsy drug market to grow with a CAGR of ...

  • Industries : Mental Health, Pathology
  • Countries : World
Deep Brain Stimulation Device Market Size, Outlook and Growth Opportunities, 2019- 2025

Deep Brain Stimulation Device Market Size, Outlook and Growth Opportunities, 2019- 2025

  • $ 4580
  • Industry report
  • June 2019

Deep Brain Stimulation Device Market Size, Outlook and Growth Opportunities, 2019- 2025Global Deep Brain Stimulation Device Market Size, Outlook and Growth Opportunities to 2025: By Type (Subthalamic DBS, ...

  • Industries : Mental Health, Pathology
  • Countries : APAC, World
Brain Implants Market Size, Outlook and Growth Opportunities, 2019- 2025

Brain Implants Market Size, Outlook and Growth Opportunities, 2019- 2025

  • $ 4580
  • Industry report
  • June 2019

Brain Implants Market Size, Outlook and Growth Opportunities, 2019- 2025Global Brain Implants Market Size, Outlook and Growth Opportunities to 2025: By Product (Deep Brain Stimulator, Spinal Cord Stimuator, ...

  • Industries : Mental Health, Pathology
  • Countries : APAC, World
Interventional Neuroradiology Market to 2027- Global Analysis and Forecasts by Product; Disease; End User and Geography

Interventional Neuroradiology Market to 2027- Global Analysis and Forecasts by Product; Disease; End User and Geography

  • $ 4550
  • Industry report
  • May 2019

The global interventional neuroradiology market is expected to reach US$ 3,254.55 Mn in 2027 from US$ 1,969.39 Mn in 2018. The market is estimated to grow with a CAGR of 5.9% from 2019-2027.Progressive ...

  • Industries : Health Services, Healthcare, Pathology
  • Countries : World
Nurse Call Systems Market to 2027 - Global Analysis and Forecasts By Equipment, Technology, Application, End User and Geography

Nurse Call Systems Market to 2027 - Global Analysis and Forecasts By Equipment, Technology, Application, End User and Geography

  • $ 4550
  • Industry report
  • April 2019

The global nurse call systems market is expected to reach US$ 2,936.83 Mn in 2027 from US$ 1,252.65 Mn in 2018. The market is estimated to grow with a CAGR of 10.3% from 2019-2027.The growth of the nurse ...

  • Industries : Healthcare, Health Services
  • Countries : World, North America
Global Duloxetine Intermediate & Atorvastatin Intermediates Market Research Report Forecast to 2023

Global Duloxetine Intermediate & Atorvastatin Intermediates Market Research Report Forecast to 2023

  • $ 4450
  • Industry report
  • May 2019

Global Duloxetine Intermediate & Atorvastatin Intermediates Market: Information by Intermediate Type (Duloxetine Intermediates and Atorvastatin Intermediates) and Region (North America, Europe, Asia-Pacific ...

  • Industries : Therapy, Pharmaceutical
  • Countries : World, United States, North America
Alzheimer’s Disease Diagnostics and Therapeutics Market - Growth, Trends, and Forecast (2019 - 2024)

Alzheimer’s Disease Diagnostics and Therapeutics Market - Growth, Trends, and Forecast (2019 - 2024)

  • $ 4250
  • Industry report
  • June 2019

Market OverviewThe global Alzheimer’s disease diagnostics and therapeutics market was valued at USD 7,537.4 million in 2018, and is estimated to be valued at USD 11,138.2 million in 2024, witnessing ...

  • Industries : Therapy, Mental Health, Pharmaceutical, Pathology, Diagnostics, Healthcare
  • Countries : World, United States, North America
Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

  • $ 4000
  • Industry report
  • May 2019

Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019SummaryGlobalData’s Medical Devices sector report, “Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, ...

  • Industries : Pharmaceutical
  • Countries : United States
Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

  • $ 4000
  • Industry report
  • May 2019

Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019SummaryGlobalData’s Medical Devices sector report, “Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, ...

  • Industries : Pharmaceutical
  • Countries : United States
MRI (Magnetic Resonance Imaging) Systems - Medical Devices Pipeline Assessment, 2019

MRI (Magnetic Resonance Imaging) Systems - Medical Devices Pipeline Assessment, 2019

  • $ 4000
  • Industry report
  • May 2019

MRI (Magnetic Resonance Imaging) Systems - Medical Devices Pipeline Assessment, 2019SummaryGlobalData’s Medical Devices sector report, “MRI (Magnetic Resonance Imaging) Systems - Medical Devices Pipeline ...

  • Industries : Diagnostic Imaging, Medical Device, Drug Development
  • Countries : United States
Insulin Like Growth Factor II - Pipeline Review, H1 2019

Insulin Like Growth Factor II - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • June 2019

Insulin Like Growth Factor II - Pipeline Review, H1 2019SummaryInsulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) pipeline Target constitutes close to 8 molecules. Out ...

  • Industries : Therapy, Mental Health, Pathology, Pharmaceutical
  • Countries : World, United States
Sphingosine 1-Phosphate Receptor 1 - Pipeline Review, H1 2019

Sphingosine 1-Phosphate Receptor 1 - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • June 2019

Sphingosine 1-Phosphate Receptor 1 - Pipeline Review, H1 2019SummarySphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States, World
Metabotropic Glutamate Receptor 3 - Pipeline Review, H1 2019

Metabotropic Glutamate Receptor 3 - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • June 2019

Metabotropic Glutamate Receptor 3 - Pipeline Review, H1 2019SummaryMetabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) pipeline Target constitutes close to 9 molecules. Out of which approximately ...

  • Industries : Mental Health, Therapy, Pathology, Pharmaceutical
  • Countries : World
Insulin Like Growth Factor I - Pipeline Review, H1 2019

Insulin Like Growth Factor I - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • June 2019

Insulin Like Growth Factor I - Pipeline Review, H1 2019SummaryAccording to the recently published report ’Insulin Like Growth Factor I - Pipeline Review, H1 2019’; Insulin Like Growth Factor I (Mechano ...

  • Industries : Therapy, Mental Health, Pathology, Pharmaceutical
  • Countries : World, United States
Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A - Pipeline Review, H1 2019

Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • June 2019

Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A - Pipeline Review, H1 2019SummaryDual Specificity Tyrosine Phosphorylation Regulated Kinase 1A (Serine/Threonine Kinase MNB or MNB/DYRK Protein ...

  • Industries : Pathology, Mental Health, Therapy, Chronic Disease
  • Countries : United States
Metabotropic Glutamate Receptor 5 - Pipeline Review, H1 2019

Metabotropic Glutamate Receptor 5 - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • May 2019

Metabotropic Glutamate Receptor 5 - Pipeline Review, H1 2019SummaryMetabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) pipeline Target constitutes close to 23 molecules. Out of which approximately ...

  • Industries : Mental Health, Pathology
  • Countries : United States, World
Metabotropic Glutamate Receptor 2 - Pipeline Review, H1 2019

Metabotropic Glutamate Receptor 2 - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • May 2019

Metabotropic Glutamate Receptor 2 - Pipeline Review, H1 2019SummaryMetabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Metabotropic glutamate receptor 2 is a protein encoded by the GRM2 gene. ...

  • Industries : Mental Health, Pathology, Therapy
  • Countries : World, United States
Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) - Pipeline Review, H1 2019

Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) - Pipeline Review, H1 2019SummaryAlpha Synuclein (Non A Beta Component Of AD Amyloid or Non ...

  • Industries : Mental Health, Pathology, Therapy
  • Countries : United States
Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2019

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2019SummaryNeuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Neuronal acetylcholine receptor subunit alpha-7 is a ...

  • Industries : Mental Health, Pathology, Pharmaceutical, Therapy
  • Countries : United States, World
Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H1 2019

Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H1 ...

  • Industries : Therapy, Mental Health, Pathology, Pharmaceutical
  • Countries : United States
Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H1 2019

Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H1 2019SummaryAccording to the recently published report ’Survival Motor Neuron Protein - Pipeline Review, ...

  • Industries : Therapy, Pharmaceutical, Mental Health
  • Countries : United States, World
Depressive Disorders: Pipeline Review, Developer Landscape and Competitive Insights

Depressive Disorders: Pipeline Review, Developer Landscape and Competitive Insights

  • $ 2999
  • Industry report
  • April 2019

OverviewDepression is a chronic medical condition characterized by a persistent feeling of sadness and lack of interest in external stimuli. It is a commonly diagnosed mental health disorder and is considered ...

  • Industries : Mental Health
Diabetic Neuropathy Global Clinical Trials Review, H1, 2019

Diabetic Neuropathy Global Clinical Trials Review, H1, 2019

  • $ 2500
  • Industry report
  • May 2019

Diabetic Neuropathy Global Clinical Trials Review, H1, 2019SummaryGlobalData’s clinical trial report, “Diabetic Neuropathy Global Clinical Trials Review, H1, 2019" provides an overview of Diabetic ...

  • Industries : Drug Development, Pharmaceutical, Therapy, Mental Health, Pathology
  • Countries : World
Duchenne Muscular Dystrophy Global Clinical Trials Review, H1, 2019

Duchenne Muscular Dystrophy Global Clinical Trials Review, H1, 2019

  • $ 2500
  • Industry report
  • May 2019

Duchenne Muscular Dystrophy Global Clinical Trials Review, H1, 2019SummaryGlobalData’s clinical trial report, “Duchenne Muscular Dystrophy Global Clinical Trials Review, H1, 2019" provides an overview ...

  • Industries : Pharmaceutical, Therapy, Drug Development, Mental Health, Pathology, Medical Biotechnology
  • Countries : World
Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2019

Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2019

  • $ 2500
  • Industry report
  • May 2019

Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2019SummaryGlobalData’s clinical trial report, “Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2019" provides an overview ...

  • Industries : Pathology, Therapy, Chronic Disease, Pharmaceutical, Drug Development
  • Countries : World

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on